Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions.
Celebrating 90 years of innovation #UCB90
Twitter Feed
-
@producerjoe We're required to report adverse events & product complaints for UCB drugs to the health authority. Visit https://t.co/Zb7Rv0gI0p for info.
— UCB News (@ucb_news) 13.11.2018 -
Have you heard about the UN Sustainable Development Goals? They are a universal call to action to address global challenges. UCB is working toward achieving SDG #3: Good Health and Well-being #UCB90 #GlobalGoals #CSR https://t.co/M4QsNRr8dv
— UCB News (@ucb_news) 12.11.2018 -
Did you know that UCB was ranked # 4th in the 2018 Global 100 Most Sustainable Corporations in the World?#UCB90 #CSR #Environment https://t.co/uSvdtMXdLf
— UCB News (@ucb_news) 07.11.2018
Highlights
At UCB, we take our responsibility to the planet very seriously.
UCB Ventures, a strategic corporate venture fund established in 2017 to further strengthen UCB’s ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases, has announced its first direct investment.
